Jafron Biomedical Co Ltd (300529) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Jafron Biomedical Co Ltd (300529) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥35.34 Million ≈ $5.17 Million USD) by net assets (CN¥3.43 Billion ≈ $501.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Jafron Biomedical Co Ltd for the company's overall valuation and market capitalisation.

Jafron Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Jafron Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jafron Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jafron Biomedical Co Ltd ranked by their cash flow conversion efficiency. Explore 300529 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Formula Systems (1985) Ltd F:FSY	N/A
CJ Cheiljedang KO:097950	0.045x
Vardhman Textiles Limited NSE:VTL	0.068x
Ola Electric Mobility Ltd NSE:OLAELEC	-0.066x
Alembic Pharmaceuticals Limited NSE:APLLTD	0.076x
Lakefront Biotherapeutics NV NASDAQ:LKFT	-0.010x
Beijing Ctrowell Technology Corp Ltd SHE:300455	0.038x
Porton Fine Chemicals Ltd SHE:300363	0.023x

Annual Cash Flow Conversion Efficiency for Jafron Biomedical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jafron Biomedical Co Ltd from 2011 to 2025. View Jafron Biomedical Co Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.47 Billion ≈ $507.96 Million	CN¥721.22 Million ≈ $105.54 Million	0.208x	-34.08%
2024-12-31	CN¥3.33 Billion ≈ $487.97 Million	CN¥1.05 Billion ≈ $153.79 Million	0.315x	+8.39%
2023-12-31	CN¥3.15 Billion ≈ $461.36 Million	CN¥916.74 Million ≈ $134.15 Million	0.291x	+18.12%
2022-12-31	CN¥3.59 Billion ≈ $525.40 Million	CN¥883.80 Million ≈ $129.33 Million	0.246x	-33.34%
2021-12-31	CN¥3.38 Billion ≈ $495.13 Million	CN¥1.25 Billion ≈ $182.83 Million	0.369x	+9.28%
2020-12-31	CN¥2.83 Billion ≈ $414.65 Million	CN¥957.49 Million ≈ $140.11 Million	0.338x	+25.70%
2019-12-31	CN¥2.17 Billion ≈ $317.62 Million	CN¥583.50 Million ≈ $85.38 Million	0.269x	+20.52%
2018-12-31	CN¥1.72 Billion ≈ $251.97 Million	CN¥384.08 Million ≈ $56.20 Million	0.223x	+2.07%
2017-12-31	CN¥1.39 Billion ≈ $203.62 Million	CN¥304.10 Million ≈ $44.50 Million	0.219x	+44.85%
2016-12-31	CN¥1.18 Billion ≈ $173.26 Million	CN¥178.64 Million ≈ $26.14 Million	0.151x	-58.52%
2015-12-31	CN¥564.06 Million ≈ $82.54 Million	CN¥205.18 Million ≈ $30.02 Million	0.364x	+19.81%
2014-12-31	CN¥452.42 Million ≈ $66.20 Million	CN¥137.35 Million ≈ $20.10 Million	0.304x	-13.44%
2013-12-31	CN¥380.12 Million ≈ $55.62 Million	CN¥133.33 Million ≈ $19.51 Million	0.351x	-15.17%
2012-12-31	CN¥290.84 Million ≈ $42.56 Million	CN¥120.25 Million ≈ $17.60 Million	0.413x	+15.66%
2011-12-31	CN¥215.57 Million ≈ $31.54 Million	CN¥77.06 Million ≈ $11.28 Million	0.357x	--

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$1.76 Billion

CN¥12.00 Billion CNY

Market Cap Rank

#6650 Global

#1345 in China

Share Price

CN¥15.03

Change (1 day)

+0.87%

52-Week Range

CN¥14.86 - CN¥22.72

All Time High

CN¥96.12